The update on their operations was minimal with no new content, so hard to read anything there.
The following is taken from page 3 of the report and spells out their cash position:
The Company’s cash position at 31 December 2016 was $3.45 million. Expenditure for the half year was $3.66 million, which included approximately $0.29 million for one-off items, so annualised recurrent expenditure is running at the rate of $6.74 million. Since the end of the reporting period, $A2.49m of accrued revenue at that date has been received and the 2016 tax return has been lodged, which will result in an estimated receipt of $2.2m during the March 2017 quarter.
So as I read it, they started the calendar year with cash of $3.45m + $4.69m accrued = $8.14m
SoT
DYOR
- Forums
- ASX - By Stock
- PYC
- Ann: Half Yearly Report and Accounts
PYC
pyc therapeutics limited
Add to My Watchlist
1.97%
!
$1.30

Ann: Half Yearly Report and Accounts, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.30 |
Change
0.025(1.97%) |
Mkt cap ! $755.3M |
Open | High | Low | Value | Volume |
$1.27 | $1.31 | $1.27 | $258.9K | 200.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3158 | $1.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.30 | 27132 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3158 | 1.270 |
2 | 15305 | 1.265 |
2 | 16318 | 1.260 |
1 | 12000 | 1.255 |
2 | 101600 | 1.250 |
Price($) | Vol. | No. |
---|---|---|
1.295 | 27132 | 2 |
1.300 | 67329 | 2 |
1.305 | 1318 | 1 |
1.310 | 1318 | 1 |
1.315 | 1318 | 1 |
Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |